Navigation Links
China Pharma Holdings, Inc. Reports Second Quarter 2011 Financial Results
Date:8/11/2011

HAIKOU CITY, China, Aug. 11, 2011 /PRNewswire-Asia-FirstCall/ -- China Pharma Holdings, Inc. (NYSE AMEX: CPHI) ("China Pharma" or the "Company"), a specialty pharmaceuticals company in China, today announced financial results for the quarter ended June 30, 2011.

Second Quarter 2011 Highlights

  • Revenue increased 18% to $19.6 million from $16.6 million in the Second quarter of 2010.
  • Cashflow from operations rose 10% to $3.6 million from $3.3 million in first six months of 2010.
  • Net income, excluding the impact of change in fair value of derivative liability, fell 9% to $4.8 million, compared to $5.3 million in the second quarter of 2010 due to lower gross margins and higher tax rate in 2011.

  • "In the second quarter of 2011 we achieved solid sales growth primarily due to strong performances by our Anti-Viro Infection & Respiratory and our CNS Cerebral and Cardio Vascular product categories. We continue to face pricing pressures across several of our product categories during the quarter, but we expect gross margin and revenue to benefit from anticipated launches of Candesartan and Rosuvasatin in the months ahead," said Ms. Zhilin Li, China Pharma's Chairman and CEO. "In addition to the expected launch of these two higher margin products, we continue to advance our novel cephalosporin-based combination antibiotic through Phase II clinical trials. Commercializing exciting new drugs like this, along with first-to-market generic medicines, is an important part of our strategy to enhance China Pharma's growth and profitability."  

    Second Quarter 2011 ResultsRevenues for the quarter ended June 30, 2011 were $19.6 million, up 18% from revenues of $16.6 million for the quarter ended June 30, 2010. Sales growth in the second quarter was led by the Anti-Viro Infection & Respiratory and also the C
    '/>"/>

    SOURCE China Pharma Holdings, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10

    Related medicine technology :

    1. China Medical Technologies Announces SFDA Approvals for its Prostate Cancer FISH Detection Kit and TOP2A FISH Detection Kit
    2. China Medical Technologies Announces the First Inclusion of FISH Tests for Diagnosis of Certain Hematological Malignancies in the Clinical Guidelines Issued by the MOH
    3. China Sky One Medical Announces Second Quarter 2011 Results
    4. China Medical Technologies and Leica Microsystems Announce Collaboration
    5. China Sky One Medical Announces Conference Call to Discuss Second Quarter 2011 Results
    6. China Nepstar Chain Drugstore to Report Second Quarter 2011 Financial Results on August 23
    7. China Medical Technologies to Announce Results for the First Fiscal Quarter Ended June 30, 2011 on August 16, 2011
    8. China Pharma Holdings, Inc. to Report Second Quarter 2011 Financial Results on August 11, 2011
    9. China Orthopedic Devices Market Outlook to 2017 - Joint Reconstruction, Spinal Surgery, Orthobiologics, Trauma Fixation and Others
    10. China Kanghui Holdings to Report Second Quarter 2011 Financial Results on August 16, 2011
    11. China Nuvo Solar Target Acquisition SurgLine Announces Third-Party Distribution Agreement With OptiMedical, Corp.
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2015)... Health today reported fourth-quarter fiscal year 2015 revenues ... and non-GAAP diluted earnings per share (EPS) from ... percent. Non-GAAP operating earnings increased 33 percent to ... increased 44 percent to $558 million, and diluted ... $0.88. Fiscal year 2015 revenues increased ...
    (Date:7/30/2015)... Ind., July 30, 2015 , Net Sales ... the prior year period and an increase of 5.7% constant ... second quarter was $(0.91), and adjusted earnings per share were ... , Company updates guidance Zimmer Biomet ... for the quarter ended June 30, 2015.  The Company reported ...
    (Date:7/29/2015)... -- Roche (SIX: RO, ROG; OTCQX: RHHBY) today ... Test v2 for Premarket Approval (PMA) to the ... companion diagnostic test for AZD9291, an AstraZeneca investigational ... an acquired resistant mutation.  Patients ... with tumor containing an EGFR sensitizing mutation show ...
    Breaking Medicine Technology:Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 2Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 3Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 4Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 5Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 6Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 7Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 8Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 9Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 10Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 11Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 12Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 13Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 14Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 15Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 16Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 17Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 18Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 19Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 20Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 21Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 22Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 23Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 24Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 25Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 26Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 27Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 28Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 29Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 30Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 31Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 32Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 33Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 34Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 35Cardinal Health Reports Strong Q4 And Record Fiscal Year-End Non-GAAP Operating Earnings Results 36
    ... Minn., Nov. 17, 2010 People who are searching ... with less potential for flushing can turn to Slo-Niacin®. ... Slo-Niacin® is a niacin supplement that has been shown ... "Slo-Niacin® features a unique patented polygel® system ...
    ... Sutro Biopharma today announced that the company has ... financing will support the company,s ongoing development of ... the company,s biochemical protein synthesis platform to meet ... Led by Skyline Ventures, the financing round, ...
    Cached Medicine Technology:Slo-Niacin® Dietary Supplement Shown to Support 'Good' Cholesterol (HDL) 2Slo-Niacin® Dietary Supplement Shown to Support 'Good' Cholesterol (HDL) 3Slo-Niacin® Dietary Supplement Shown to Support 'Good' Cholesterol (HDL) 4Sutro Biopharma Secures $36.5 Million in Series C Financing 2
    (Date:7/30/2015)... ... July 30, 2015 , ... Western University of Health Sciences faculty, students and ... Games, the largest sports and humanitarian event in the world this year and the ... Games, held July 25 through August 2, 2015, benefited from the participation of WesternU’s ...
    (Date:7/30/2015)... Wisconsin (PRWEB) , ... July 30, 2015 , ... Quintessa ... Kybella is a nonsurgical treatment designed specifically for the elimination of ... one of the first locations in the state of Wisconsin to offer this innovative ...
    (Date:7/30/2015)... ... July 30, 2015 , ... The New ... the New Jersey Department of Health, has received a $2.9 million grant from ... the U.S. Department of Health and Human Services (HHS). NJII will help the ...
    (Date:7/30/2015)... ... ... Bird B Gone, the leader in bird control products for commercial, industrial and ... from the AC units and ventilation systems on hospital roofs. Bird droppings can carry ... virus. When these droppings dry, the fine powder can be carried into hospitals via ...
    (Date:7/30/2015)... ... ... After conducting a nationwide executive search led by healthcare leadership solutions firm ... N.Y., has hired Gerard (Jerry) Walsh as Chief Executive Officer. Walsh assumed his new ... Walsh is an expert in organizational change, physician development, implementation of quality and patient ...
    Breaking Medicine News(10 mins):Health News:WesternU Makes Big Impact at Special Olympics 2Health News:WesternU Makes Big Impact at Special Olympics 3Health News:Quintessa MedSpa Offers Nonsurgical Double-chin Elimination 2Health News:New Jersey Innovation Institute Awarded $2.9 Million Federal Grant to Advance Health Information Technology Services to Support Health Information Exchange 2Health News:Bird B Gone’s New Bird Hazing System Keeps Disease-Carrying Bird Droppings Out of Hospitals 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 2Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 3Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 4Health News:St. John’s Episcopal Hospital Hires New Chief Executive Officer 5
    ... sometimes a barrier for patients when it comes to ... barrier increases the risk that a patient will use ... suffer an adverse drug event. , , ScriptPro ... instructions and drug auxiliary warnings, and print them on ...
    ... receptors was shown to double survival time in mice, according ... phase animal model study were reported in the June 15 ... Care Medicine . Changes in genes encoding nicotine ... smoke, but with susceptibility to lung cancer. Nicotine exposure also ...
    ... issued today, the nonpartisan watchdog group Public Campaign Action Fund ... health care reform as "hazardous to America,s health, and a ... working families and small business owners in Kentucky." , ... Sen. McConnell,s opposition to health care legislation that includes a ...
    ... , Additional Group of Compounds and Enhanced Research Activities ... 8 Senetek PLC (OTC Bulletin Board: SNKTY), a ... technologies that target the science of healthy aging, announced ... agreement with the Czech Republic Institute of Experimental Botany ...
    ... Health Alliance Design Guidelines , , SAN RAMON, ... Alliance announced today that the Continua Health Alliance has ... local area network (LAN) standard. ZigBee Health Care offers ... single network. Continua recommends ZigBee for sensing and control ...
    ... Solution to Help Employees Lose Weight, Be Healthy and Save Money ... NTRI ), a leading provider of weight management products ... Nutrisystem Works(TM) program to companies and health plans across ... costs. The obesity epidemic continues to rise and studies have ...
    Cached Medicine News:Health News:Robot Speaks Many Languages - Improves Pharmacy Patient Outcomes 2Health News:Defeating nicotine's double role in lung cancer 2Health News:Defeating nicotine's double role in lung cancer 3Health News:Watchdog Group Blasts McConnell for Putting Insurance Donors Before Health Care Reform 2Health News:Senetek PLC Gains Six Year Extension of Rights from Czech Republic Institute of Experimental Botany 2Health News:Senetek PLC Gains Six Year Extension of Rights from Czech Republic Institute of Experimental Botany 3Health News:ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 2Health News:ZigBee Selected by Continua Health Alliance for Next Generation Guidelines 3Health News:New Nutrisystem Works(TM) Offers Corporate America New Weapon in the Fight Against Obesity 2Health News:New Nutrisystem Works(TM) Offers Corporate America New Weapon in the Fight Against Obesity 3Health News:New Nutrisystem Works(TM) Offers Corporate America New Weapon in the Fight Against Obesity 4